PLN 3.7
(0.82%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 117.91 Million PLN | 7.17% |
2022 | 110.02 Million PLN | -11.81% |
2021 | 124.75 Million PLN | 40.36% |
2020 | 88.87 Million PLN | 12.9% |
2019 | 78.72 Million PLN | 2.57% |
2018 | 76.75 Million PLN | -26.64% |
2017 | 104.62 Million PLN | -10.41% |
2016 | 116.79 Million PLN | 11.26% |
2015 | 104.96 Million PLN | 20.39% |
2014 | 87.19 Million PLN | 34.26% |
2013 | 64.94 Million PLN | -22.87% |
2012 | 84.2 Million PLN | -11.63% |
2011 | 95.28 Million PLN | -3.15% |
2010 | 98.38 Million PLN | -12.04% |
2009 | 111.85 Million PLN | 20.31% |
2008 | 92.97 Million PLN | -6.68% |
2007 | 99.63 Million PLN | 60.71% |
2006 | 61.99 Million PLN | 47.98% |
2005 | 41.89 Million PLN | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 122.56 Million PLN | 3.55% |
2024 Q1 | 118.36 Million PLN | 0.38% |
2023 FY | 117.91 Million PLN | 7.17% |
2023 Q1 | 122.4 Million PLN | 11.26% |
2023 Q3 | 113.12 Million PLN | -5.42% |
2023 Q2 | 119.6 Million PLN | -2.29% |
2023 Q4 | 117.91 Million PLN | 4.24% |
2022 Q2 | 120.55 Million PLN | 4.45% |
2022 Q1 | 115.42 Million PLN | -7.48% |
2022 FY | 110.02 Million PLN | -11.81% |
2022 Q4 | 110.02 Million PLN | -4.9% |
2022 Q3 | 115.69 Million PLN | -4.03% |
2021 FY | 124.75 Million PLN | 40.36% |
2021 Q2 | 111.19 Million PLN | 12.7% |
2021 Q1 | 98.66 Million PLN | 11.01% |
2021 Q3 | 113.31 Million PLN | 1.91% |
2021 Q4 | 124.75 Million PLN | 10.09% |
2020 FY | 88.87 Million PLN | 12.9% |
2020 Q2 | 89.9 Million PLN | 9.82% |
2020 Q3 | 99.42 Million PLN | 10.59% |
2020 Q4 | 88.87 Million PLN | -10.61% |
2020 Q1 | 81.85 Million PLN | 3.98% |
2019 FY | 78.72 Million PLN | 2.57% |
2019 Q1 | 74.61 Million PLN | -2.78% |
2019 Q2 | 75.13 Million PLN | 0.7% |
2019 Q3 | 83.4 Million PLN | 11.0% |
2019 Q4 | 78.72 Million PLN | -5.61% |
2018 FY | 76.75 Million PLN | -26.64% |
2018 Q4 | 76.75 Million PLN | -14.23% |
2018 Q1 | 110.69 Million PLN | 5.8% |
2018 Q2 | 92.93 Million PLN | -16.05% |
2018 Q3 | 89.48 Million PLN | -3.71% |
2017 Q4 | 104.62 Million PLN | -13.05% |
2017 Q2 | 133.79 Million PLN | 3.51% |
2017 Q1 | 129.26 Million PLN | 10.68% |
2017 FY | 104.62 Million PLN | -10.41% |
2017 Q3 | 120.33 Million PLN | -10.06% |
2016 Q3 | 114.89 Million PLN | -3.62% |
2016 Q1 | 111.59 Million PLN | 6.32% |
2016 FY | 116.79 Million PLN | 11.26% |
2016 Q2 | 119.21 Million PLN | 6.83% |
2016 Q4 | 116.79 Million PLN | 1.65% |
2015 Q1 | 94.08 Million PLN | 7.9% |
2015 FY | 104.96 Million PLN | 20.39% |
2015 Q4 | 104.96 Million PLN | -3.8% |
2015 Q3 | 109.11 Million PLN | -2.24% |
2015 Q2 | 111.6 Million PLN | 18.63% |
2014 Q3 | 85.77 Million PLN | -0.74% |
2014 Q4 | 87.19 Million PLN | 1.65% |
2014 Q2 | 86.41 Million PLN | 12.48% |
2014 FY | 87.19 Million PLN | 34.26% |
2014 Q1 | 76.82 Million PLN | 18.3% |
2013 Q3 | 73.98 Million PLN | 1.33% |
2013 Q4 | 64.94 Million PLN | -12.22% |
2013 FY | 64.94 Million PLN | -22.87% |
2013 Q1 | 82.35 Million PLN | -2.2% |
2013 Q2 | 73.01 Million PLN | -11.34% |
2012 Q3 | 88.66 Million PLN | -6.69% |
2012 Q1 | 93.03 Million PLN | -2.36% |
2012 Q4 | 84.2 Million PLN | -5.03% |
2012 FY | 84.2 Million PLN | -11.63% |
2012 Q2 | 95.01 Million PLN | 2.13% |
2011 Q3 | 102.56 Million PLN | -5.24% |
2011 Q4 | 95.28 Million PLN | -7.09% |
2011 FY | 95.28 Million PLN | -3.15% |
2011 Q1 | 103.81 Million PLN | 5.52% |
2011 Q2 | 108.23 Million PLN | 4.26% |
2010 Q2 | 108.53 Million PLN | -2.35% |
2010 Q1 | 111.15 Million PLN | -0.63% |
2010 FY | 98.38 Million PLN | -12.04% |
2010 Q4 | 98.38 Million PLN | -7.83% |
2010 Q3 | 106.74 Million PLN | -1.66% |
2009 Q4 | 111.85 Million PLN | 0.0% |
2009 FY | 111.85 Million PLN | 20.31% |
2008 FY | 92.97 Million PLN | -6.68% |
2007 FY | 99.63 Million PLN | 60.71% |
2006 FY | 61.99 Million PLN | 47.98% |
2005 FY | 41.89 Million PLN | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Bioceltix S.A. | 8617.89 PLN | -1368193.167% |
Captor Therapeutics Spolka Akcyjna | - PLN | -Infinity% |
Mabion S.A. | 6.84 Million PLN | -1623.192% |
Molecure S.A. | - PLN | -Infinity% |
NanoGroup S.A. | 63.37 Thousand PLN | -185955.098% |
Pharmena S.A. | 445 Thousand PLN | -26398.427% |
Poltreg S.A. | 415 Thousand PLN | -28313.976% |
Pure Biologics Spólka Akcyjna | 17.56 Million PLN | -571.247% |
Ryvu Therapeutics S.A. | 2.11 Million PLN | -5467.422% |
Synthaverse S.A. | 15.48 Million PLN | -661.547% |
Urteste S.A. | 162 Thousand PLN | -72688.889% |